Cargando…
Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin
BACKGROUND: Protein arginine methyltransferase 5 (PRMT5), a type II PRMT, is highly expressed in some tumors, but its role in hepatocellular carcinoma (HCC) is still unknown. METHODS: PRMT5 level in HCC specimens was determined by immunohistochemical staining and the association with clinicopatholog...
Autores principales: | Zhang, Baolai, Dong, Shuhong, Li, Zhongxin, Lu, Li, Zhang, Su, Chen, Xue, Cen, Xiaobo, Wu, Yongjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635578/ https://www.ncbi.nlm.nih.gov/pubmed/26541651 http://dx.doi.org/10.1186/s12967-015-0721-8 |
Ejemplares similares
-
Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3
por: Zhang, Baolai, et al.
Publicado: (2015) -
Arginine methyltransferase inhibitor-1 inhibits sarcoma viability in vitro and in vivo
por: Zhang, Baolai, et al.
Publicado: (2018) -
Protein arginine methyltransferases and hepatocellular carcinoma: A review
por: Lei, Yu, et al.
Publicado: (2021) -
Downregulation of histone methyltransferase SET8 inhibits progression of hepatocellular carcinoma
por: Wu, Jianhua, et al.
Publicado: (2020) -
Protein arginine methyltransferase 3 promotes glycolysis and hepatocellular carcinoma growth by enhancing arginine methylation of lactate dehydrogenase A
por: Lei, Yu, et al.
Publicado: (2022)